The global DVT treatment devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of patients suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE). The increasing prevalence of these diseases is due to factors such as sedentary lifestyle, obesity, and genetic predisposition.
The venous stenting segment accounted for the largest share in the global DVT treatment devices market in 2018. This segment is expected to continue its dominance throughout the forecast period owing to its high adoption rate among hospitals and clinics for treating DVT cases. The compression stockings segment accounted for a significant share in 2018 owing to their low cost and ease of use. However, it is expected that this segment will lose its dominance over time due to their limited efficacy in preventing PEs when compared with other treatments such as venous stenting or catheter-directed thrombolysis (CDT).
Some Of The Growth Factors Of This Market:
- The increasing number of people suffering from chronic diseases such as diabetes and obesity is expected to drive the demand for DVT treatment devices in the near future.
- The growing awareness about DVT among people is also expected to fuel the growth of this market in the coming years.
- The increasing number of hospitals and clinics offering treatments for DVT is also expected to boost the demand for these devices in this market during the forecast period.
- Increasing research and development activities by manufacturers are also anticipated to fuel growth in this market during the forecast period.
- Increasing government funding on research and development activities related to these devices is also anticipated to have a positive impact on their demand over time.
Industry Growth Insights published a new data on “DVT Treatment Devices Market”. The research report is titled “DVT Treatment Devices Market research by Types (Venous Stenting, Compression Stockings, Others), By Applications (Clinic, Research Institutions, Hospital), By Players/Companies Bayer AG, Pharmathen Pharmaceuticals S.A., F. Hoffmann-La Roche Ltd., Dupont Pharm Co, Bristol-Myers Squibb Company, 3SBio Inc., Wockhardt Ltd, Generex Biotechnology Lorporation, Laboratorios Farmaceuticos Rovi, S.A., Pfizer Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
DVT Treatment Devices Market Research Report
By Type
Venous Stenting, Compression Stockings, Others
By Application
Clinic, Research Institutions, Hospital
By Companies
Bayer AG, Pharmathen Pharmaceuticals S.A., F. Hoffmann-La Roche Ltd., Dupont Pharm Co, Bristol-Myers Squibb Company, 3SBio Inc., Wockhardt Ltd, Generex Biotechnology Lorporation, Laboratorios Farmaceuticos Rovi, S.A., Pfizer Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global DVT Treatment Devices Market Report Segments:
The global DVT Treatment Devices market is segmented on the basis of:
Types
Venous Stenting, Compression Stockings, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Research Institutions, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Pharmathen Pharmaceuticals S.A.
- F. Hoffmann-La Roche Ltd.
- Dupont Pharm Co
- Bristol-Myers Squibb Company
- 3SBio Inc.
- Wockhardt Ltd
- Generex Biotechnology Lorporation
- Laboratorios Farmaceuticos Rovi, S.A.
- Pfizer Inc.
Highlights of The DVT Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Venous Stenting
- Compression Stockings
- Others
- By Application:
- Clinic
- Research Institutions
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DVT Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DVT treatment devices are medical devices that help to prevent DVT. These devices can be used in hospitals or clinics, and they include a variety of different types of pumps and filters.
Some of the major players in the dvt treatment devices market are Bayer AG, Pharmathen Pharmaceuticals S.A., F. Hoffmann-La Roche Ltd., Dupont Pharm Co, Bristol-Myers Squibb Company, 3SBio Inc., Wockhardt Ltd, Generex Biotechnology Lorporation, Laboratorios Farmaceuticos Rovi, S.A., Pfizer Inc..
The dvt treatment devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DVT Treatment Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DVT Treatment Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DVT Treatment Devices Market - Supply Chain
4.5. Global DVT Treatment Devices Market Forecast
4.5.1. DVT Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DVT Treatment Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. DVT Treatment Devices Market Absolute $ Opportunity
5. Global DVT Treatment Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DVT Treatment Devices Market Size and Volume Forecast by Type
5.3.1. Venous Stenting
5.3.2. Compression Stockings
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DVT Treatment Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DVT Treatment Devices Market Size and Volume Forecast by Application
6.3.1. Clinic
6.3.2. Research Institutions
6.3.3. Hospital
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DVT Treatment Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DVT Treatment Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DVT Treatment Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DVT Treatment Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DVT Treatment Devices Demand Share Forecast, 2019-2026
9. North America DVT Treatment Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DVT Treatment Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DVT Treatment Devices Market Size and Volume Forecast by Application
9.4.1. Clinic
9.4.2. Research Institutions
9.4.3. Hospital
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DVT Treatment Devices Market Size and Volume Forecast by Type
9.7.1. Venous Stenting
9.7.2. Compression Stockings
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DVT Treatment Devices Demand Share Forecast, 2019-2026
10. Latin America DVT Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DVT Treatment Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DVT Treatment Devices Market Size and Volume Forecast by Application
10.4.1. Clinic
10.4.2. Research Institutions
10.4.3. Hospital
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DVT Treatment Devices Market Size and Volume Forecast by Type
10.7.1. Venous Stenting
10.7.2. Compression Stockings
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DVT Treatment Devices Demand Share Forecast, 2019-2026
11. Europe DVT Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DVT Treatment Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DVT Treatment Devices Market Size and Volume Forecast by Application
11.4.1. Clinic
11.4.2. Research Institutions
11.4.3. Hospital
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DVT Treatment Devices Market Size and Volume Forecast by Type
11.7.1. Venous Stenting
11.7.2. Compression Stockings
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attactiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DVT Treatment Devices Demand Share, 2019-2026
12. Asia Pacific DVT Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DVT Treatment Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DVT Treatment Devices Market Size and Volume Forecast by Application
12.4.1. Clinic
12.4.2. Research Institutions
12.4.3. Hospital
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DVT Treatment Devices Market Size and Volume Forecast by Type
12.7.1. Venous Stenting
12.7.2. Compression Stockings
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DVT Treatment Devices Demand Share, 2019-2026
13. Middle East & Africa DVT Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DVT Treatment Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DVT Treatment Devices Market Size and Volume Forecast by Application
13.4.1. Clinic
13.4.2. Research Institutions
13.4.3. Hospital
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DVT Treatment Devices Market Size and Volume Forecast by Type
13.7.1. Venous Stenting
13.7.2. Compression Stockings
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DVT Treatment Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DVT Treatment Devices Market: Market Share Analysis
14.2. DVT Treatment Devices Distributors and Customers
14.3. DVT Treatment Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pharmathen Pharmaceuticals S.A.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. F. Hoffmann-La Roche Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Dupont Pharm Co
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bristol-Myers Squibb Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. 3SBio Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wockhardt Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Generex Biotechnology Lorporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Laboratorios Farmaceuticos Rovi, S.A.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Pfizer Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
